Changyan Hu

BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

S. Fuqua, E. Rosen, S. Fan, 2010, Molecular endocrinology.

Development of chiral praziquantel analogues as potential drug candidates with activity to juvenile Schistosoma japonicum.

Changyan Hu, C. Xia, Chun-hua Yang, 2014, Bioorganic & medicinal chemistry letters.

Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity.

E. Rosen, S. Fan, Yongxian Ma, 2007, Molecular endocrinology.

Metabolic profiling of praziquantel enantiomers.

J. Idle, F. Gonzalez, K. Krausz, 2014, Biochemical pharmacology.

The cytotoxicity study of praziquantel enantiomers

Ruifeng Mao, Qian Sun, Changyan Hu, 2016, Drug design, development and therapy.

Synthesis, Larvicidal Activities and Antifungal Activities of Novel Chlorantraniliprole Derivatives and Their Target in the Ryanodine Receptor

M. Luo, Li-xia Xiong, Qichao Chen, 2015, Molecules.

Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum

E. Rosen, I. Goldberg, S. Fan, 2006, Anti-cancer drugs.

Novel chlorantraniliprole derivatives as potential insecticides and probe to chlorantraniliprole binding site on ryanodine receptor.

M. Luo, Qichao Chen, Xiaomin Luo, 2014, Bioorganic & medicinal chemistry letters.